Spectral Medical Inc EDT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$1.08
- Day Range
- CA$0.98–1.07
- 52-Week Range
- CA$0.98–1.60
- Bid/Ask
- CA$1.00 / CA$1.03
- Shares Outstanding
- 293.55M
- Market Cap
- CA$293.55M
- Volume/Avg
- 134,014 / 49,814
Key Statistics
- Price/Earnings (Normalized)
- 22.27
- Price/Sales
- 113.46
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 29
- Website
- https://www.spectraldx.com
Valuation
|
Metric
|
EDT
|
|---|---|
Price/Earnings (Normalized) | 22.27 |
Price/Book Value | — |
Price/Sales | 113.46 |
Price/Cash Flow | — |
Price/Earnings
EDT
Financial Strength
|
Metric
|
EDT
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.04 |
Interest Coverage | −4.73 |
Quick Ratio
EDT
Profitability
|
Metric
|
EDT
|
|---|---|
Return on Assets (Normalized) | 223.88% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
EDT
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|?>^zx<&Y | LOCK|#> | $249B | |||
| Danaher Corp
DHR
| LOCK|@hmNNNW | LOCK|?Wb | $162B | |||
| Agilent Technologies Inc
A
| LOCK|<jMThwK? | LOCK|^Q | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|#W@WcX | LOCK|d<!fv | $46B | |||
| Waters Corp
WAT
| LOCK|ZCGx<S | LOCK|>& | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|yy!J@NY | LOCK|K>& | $44B | |||
| Illumina Inc
ILMN
| LOCK|k%@^DzR | LOCK|>M@>% | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|C%%?S^zR | LOCK|^&nj | $33B | |||
| Quest Diagnostics Inc
DGX
| LOCK|$&KV&& | LOCK|DqX@ | $27B | |||
| Labcorp Holdings Inc
LH
| LOCK|>>@f?!f | LOCK|mwmnP | $27B |
United States